na-931 vs retatrutide Everything you need to know about NA-931: a novel quadruple receptor agonist for the treatment of obesity Four Target Combination Therapy: GLP-1-GIP-GCG-IGF-1
Pay in 4 interest-free payments of $5.52 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14


























